Anzeige
Mehr »
Mittwoch, 01.10.2025 - Börsentäglich über 12.000 News
Globaler Gamechanger: CiTech expandiert in Europa - neue Chancen für Investoren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QB4E | ISIN: IL0011651580 | Ticker-Symbol:
NASDAQ
01.10.25 | 19:21
1,410 US-Dollar
-0,70 % -0,010
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PAINREFORM LTD Chart 1 Jahr
5-Tage-Chart
PAINREFORM LTD 5-Tage-Chart

Aktuelle News zur PAINREFORM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:46PainReform reduziert Nettoverlust deutlich - gemischte Fortschritte in Pharma- und Solarsparte1
15:30PAINREFORM LTD. - 6-K, Report of foreign issuer-
PAINREFORM Aktie jetzt für 0€ handeln
15:30PainReform Ltd: PainReform Provides Business Update for the Six Months Ended June 30, 202546TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization...
► Artikel lesen
19.08.PainReform Stock Soars 83% On NVIDIA Partnership For AI-Driven Solar Analytics10
19.08.PainReform's DeepSolar unit joins NVIDIA Connect Program5
19.08.PainReform Ltd: PainReform/DeepSolar Accepted into NVIDIA Connect Program4
13.08.PAINREFORM LTD. - 6-K, Report of foreign issuer1
13.08.PainReform sichert sich Mehrheitsbeteiligung an LayerBio zur Weiterentwicklung von Augenmedikament3
13.08.PainReform acquires majority stake in LayerBio to advance eye surgery drug3
13.08.PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System151TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the closing of its previously announced investment in LayerBio...
► Artikel lesen
10.07.Painreform stock falls after announcing strategic investment in LayerBio1
10.07.Painreform-Aktie fällt nach strategischer Investition in LayerBio1
10.07.PAINREFORM LTD. - 6-K, Report of foreign issuer1
07.05.PAINREFORM LTD. - 6-K, Report of foreign issuer2
07.05.PainReform Ltd: PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar Platform to Optimize One of Romania's Largest Solar Projects1
17.04.PAINREFORM LTD. - 6-K, Report of foreign issuer1
10.04.PAINREFORM LTD. - 6-K, Report of foreign issuer1
10.04.PainReform acquires DeepSolar1
10.04.PainReform Ltd: PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market2
07.04.PainReform shifts focus to clean energy with AI platform1
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1